Diasorin Receives FDA 510(k) Clearance for NxTAG® RPP v2
Diasorin
NxTag Respiratory Pathogen Panel v2 is a molecular multiplex panel that detects 21 different pathogens
respiratory diseases
A Simple Blood Test Could Detect TB in Asymptomatic Patients
University of Southampton
Tuberculosis is the world's deadliest infectious disease and kills more than 1 million people each year, per the WHO
Monocyte Count Predicts Lung Disease Risk in COVID-19 Patients
University of Virginia Health System
A simple blood test result can inform clinicians which patients with severe COVID-19 will develop long-haul lung problems
A Simple Blood Test Accurately Detects Sarcoidosis
National Institutes of Health
Per research, an estimated 8–11 people per 100,000 are affected by sarcoidosis each year in the US
First T-Cell Therapy Improves Survival in ARDS Patients
Anglia Ruskin University
Phase 1/2 trial data suggest that iNKT-cell therapy reduced systemic inflammation and pneumonia risk in patients on VV-ECMO
The Multifaceted Nature of Respiratory Tract Infections
Thermo Fisher Scientific
Fully understanding different RTIs can better inform management and testing decisions for public health
Simplify and Automate Respiratory Diagnostic Testing
Thermo Fisher Scientific
New KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows
CDC Recommends mAbs to Prevent RSV in Infants
Centers for Disease Control and Prevention
New immunization is the first approved and recommended in the US to prevent severe RSV disease in all infants
FDA Approves New Drug to Prevent RSV in Babies, Toddlers
U.S. Food and Drug Administration
Beyfortus proved to be safe and efficacious in trials with infants at varying degrees of risk for RSV infection
Novel Cystic Fibrosis Treatment Enters Clinical Trial
University of Illinois at Urbana-Champaign
Results of the trial using the CM001 inhalable drug formulation are expected in 2024